# BJs RESTAURANTS INC: financial statements, quarterly

BJRI · Nasdaq · CIK 1013488 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 3

Pages: [Overview](/companies/bjri.md) · [Financials](/companies/bjri/financials.md) · [Filings](/companies/bjri/filings.md) · [Insiders](/companies/bjri/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bjri/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-03) | Q4 FY2023 (2024-01-02) | Q1 FY2024 (2024-04-02) | Q2 FY2024 (2024-07-02) | Q3 FY2024 (2024-10-01) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-04-01) | Q2 FY2025 (2025-07-01) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [319](/filings/0000950170-24-120803.md) | [324 d](/filings/0001193125-26-083331.md) | [337](/filings/0000950170-25-063508.md) | [350](/filings/0000950170-25-105641.md) | [326](/filings/0001193125-25-266346.md) | [344 d](/filings/0001193125-26-083331.md) | [348](/filings/0001193125-26-206922.md) | [366](/filings/0001193125-26-326418.md) | [330](/filings/0001193125-25-266346.md) | [355 d](/filings/0001193125-26-083331.md) | [358](/filings/0001193125-26-206922.md) | [389](/filings/0001193125-26-326418.md) |
| Cost of revenue | $m | [82.7](/filings/0000950170-24-120803.md) | [82.4 d](/filings/0001193125-26-083331.md) | [85.0](/filings/0000950170-25-063508.md) | [89.8](/filings/0000950170-25-105641.md) | [86.7](/filings/0001193125-25-266346.md) | [89.1 d](/filings/0001193125-26-083331.md) | [86.8](/filings/0001193125-26-206922.md) | [90.8](/filings/0001193125-26-326418.md) | [84.9](/filings/0001193125-25-266346.md) | [90.8 d](/filings/0001193125-26-083331.md) | [89.9](/filings/0001193125-26-206922.md) | [99.1](/filings/0001193125-26-326418.md) |
| Operating income | $m | [(2.4)](/filings/0000950170-24-120803.md) | [3.3 d](/filings/0001193125-26-083331.md) | [8.3](/filings/0000950170-25-063508.md) | [13.2](/filings/0000950170-25-105641.md) | [(2.6)](/filings/0001193125-25-266346.md) | [(4.8) d](/filings/0001193125-26-083331.md) | [15.0](/filings/0001193125-26-206922.md) | [21.2](/filings/0001193125-26-326418.md) | [(1.0)](/filings/0001193125-25-266346.md) | [11.1 d](/filings/0001193125-26-083331.md) | [10.6](/filings/0001193125-26-206922.md) | [18.4](/filings/0001193125-26-326418.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.4](/filings/0000950170-24-120803.md) | [(6.0) d](/filings/0001193125-26-083331.md) | [(0.2)](/filings/0000950170-25-063508.md) | [(2.4)](/filings/0000950170-25-105641.md) | [(0.3)](/filings/0001193125-25-266346.md) | [(5.6) d](/filings/0001193125-26-083331.md) | [0.2](/filings/0001193125-26-206922.md) | [1.5](/filings/0001193125-26-326418.md) | [(1.5)](/filings/0001193125-25-266346.md) | [(1.8) d](/filings/0001193125-26-083331.md) | [0.1](/filings/0001193125-26-206922.md) | [0.2](/filings/0001193125-26-326418.md) |
| Net income | $m | [(3.8)](/filings/0000950170-24-120803.md) | [8.1 d](/filings/0001193125-26-083331.md) | [7.7](/filings/0000950170-25-063508.md) | [17.2](/filings/0000950170-25-105641.md) | [(2.9)](/filings/0001193125-25-266346.md) | [(5.3) d](/filings/0001193125-26-083331.md) | [13.5](/filings/0001193125-26-206922.md) | [22.2](/filings/0001193125-26-326418.md) | [0.5](/filings/0001193125-25-266346.md) | [12.6 d](/filings/0001193125-26-083331.md) | [9.0](/filings/0001193125-26-206922.md) | [18.8](/filings/0001193125-26-326418.md) |
| Diluted EPS | $ per share | [(0.16)](/filings/0000950170-24-120803.md) | not reported | [0.32](/filings/0000950170-25-063508.md) | [0.72](/filings/0000950170-25-105641.md) | [(0.13)](/filings/0001193125-25-266346.md) | not reported | [0.58](/filings/0001193125-26-206922.md) | [0.97](/filings/0001193125-26-326418.md) | [0.02](/filings/0001193125-25-266346.md) | not reported | [0.41](/filings/0001193125-26-206922.md) | [0.86](/filings/0001193125-26-326418.md) |
| Basic EPS | $ per share | [(0.16)](/filings/0000950170-24-120803.md) | not reported | [0.33](/filings/0000950170-25-063508.md) | [0.74](/filings/0000950170-25-105641.md) | [(0.13)](/filings/0001193125-25-266346.md) | not reported | [0.59](/filings/0001193125-26-206922.md) | [1.00](/filings/0001193125-26-326418.md) | [0.02](/filings/0001193125-25-266346.md) | not reported | [0.43](/filings/0001193125-26-206922.md) | [0.89](/filings/0001193125-26-326418.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-03) | FY2023 (2024-01-02) | Q1 FY2024 (2024-04-02) | Q2 FY2024 (2024-07-02) | Q3 FY2024 (2024-10-01) | FY2024 (2024-12-31) | Q1 FY2025 (2025-04-01) | Q2 FY2025 (2025-07-01) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [12.0](/filings/0000950170-23-059349.md) | [29.1](/filings/0000950170-25-027899.md) | [18.8](/filings/0000950170-24-053699.md) | [16.2](/filings/0000950170-24-090952.md) | [18.4](/filings/0000950170-24-120803.md) | [26.1](/filings/0001193125-26-083331.md) | [19.0](/filings/0000950170-25-063508.md) | [26.0](/filings/0000950170-25-105641.md) | [25.4](/filings/0001193125-25-266346.md) | [23.8](/filings/0001193125-26-326418.md) | [22.7](/filings/0001193125-26-206922.md) | [14.4](/filings/0001193125-26-326418.md) |
| Current assets | $m | [61.3](/filings/0000950170-23-059349.md) | [83.0](/filings/0000950170-25-027899.md) | [65.6](/filings/0000950170-24-053699.md) | [60.1](/filings/0000950170-24-090952.md) | [64.5](/filings/0000950170-24-120803.md) | [79.6](/filings/0001193125-26-083331.md) | [64.1](/filings/0000950170-25-063508.md) | [72.6](/filings/0000950170-25-105641.md) | [70.6](/filings/0001193125-25-266346.md) | [74.9](/filings/0001193125-26-326418.md) | [60.4](/filings/0001193125-26-206922.md) | [53.9](/filings/0001193125-26-326418.md) |
| Total assets | $m | [1,037](/filings/0000950170-23-059349.md) | [1,058](/filings/0000950170-25-027899.md) | [1,045](/filings/0000950170-24-053699.md) | [1,044](/filings/0000950170-24-090952.md) | [1,042](/filings/0000950170-24-120803.md) | [1,041](/filings/0001193125-26-083331.md) | [1,020](/filings/0000950170-25-063508.md) | [1,025](/filings/0000950170-25-105641.md) | [1,022](/filings/0001193125-25-266346.md) | [1,015](/filings/0001193125-26-326418.md) | [999](/filings/0001193125-26-206922.md) | [992](/filings/0001193125-26-326418.md) |
| Current liabilities | $m | [183](/filings/0000950170-23-059349.md) | [199](/filings/0000950170-25-027899.md) | [187](/filings/0000950170-24-053699.md) | [172](/filings/0000950170-24-090952.md) | [183](/filings/0000950170-24-120803.md) | [196](/filings/0001193125-26-083331.md) | [164](/filings/0000950170-25-063508.md) | [190](/filings/0000950170-25-105641.md) | [194](/filings/0001193125-25-266346.md) | [188](/filings/0001193125-26-326418.md) | [193](/filings/0001193125-26-206922.md) | [186](/filings/0001193125-26-326418.md) |
| Total liabilities | $m | [676](/filings/0000950170-23-059349.md) | [693](/filings/0000950170-25-027899.md) | [670](/filings/0000950170-24-053699.md) | [658](/filings/0000950170-24-090952.md) | [666](/filings/0000950170-24-120803.md) | [671](/filings/0001193125-26-083331.md) | [648](/filings/0000950170-25-063508.md) | [639](/filings/0000950170-25-105641.md) | [666](/filings/0001193125-25-266346.md) | [649](/filings/0001193125-26-326418.md) | [627](/filings/0001193125-26-206922.md) | [594](/filings/0001193125-26-326418.md) |
| Long-term debt | $m | [60.0](/filings/0000950170-23-059349.md) | [68.0](/filings/0000950170-25-027899.md) | [58.0](/filings/0000950170-24-053699.md) | [63.5](/filings/0000950170-24-090952.md) | [66.5](/filings/0000950170-24-120803.md) | [66.5](/filings/0001193125-26-083331.md) | [85.5](/filings/0000950170-25-063508.md) | [60.5](/filings/0000950170-25-105641.md) | [89.5](/filings/0001193125-25-266346.md) | [85.0](/filings/0001193125-26-326418.md) | [62.0](/filings/0001193125-26-206922.md) | [44.0](/filings/0001193125-26-326418.md) |
| Shareholders' equity | $m | [361](/filings/0000950170-24-120803.md) | [366](/filings/0001193125-26-083331.md) | [375](/filings/0000950170-25-105641.md) | [386](/filings/0001193125-25-266346.md) | [376](/filings/0001193125-25-266346.md) | [370](/filings/0001193125-26-326418.md) | [371](/filings/0001193125-26-326418.md) | [387](/filings/0001193125-26-326418.md) | [356](/filings/0001193125-25-266346.md) | [366](/filings/0001193125-26-326418.md) | [373](/filings/0001193125-26-326418.md) | [397](/filings/0001193125-26-326418.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-03) | Q4 FY2023 (2024-01-02) | Q1 FY2024 (2024-04-02) | Q2 FY2024 (2024-07-02) | Q3 FY2024 (2024-10-01) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-04-01) | Q2 FY2025 (2025-07-01) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [32.0 d](/filings/0000950170-24-120803.md) | [32.2 d](/filings/0001193125-26-083331.md) | [22.3](/filings/0000950170-25-063508.md) | [20.2 d](/filings/0000950170-25-105641.md) | [27.3 d](/filings/0001193125-25-266346.md) | [31.6 d](/filings/0001193125-26-083331.md) | [4.6](/filings/0001193125-26-206922.md) | [62.3 d](/filings/0001193125-26-326418.md) | [25.1 d](/filings/0001193125-25-266346.md) | [18.6 d](/filings/0001193125-26-083331.md) | [43.0](/filings/0001193125-26-206922.md) | [31.1 d](/filings/0001193125-26-326418.md) |
| Capital expenditure | $m | [29.1 d](/filings/0000950170-24-120803.md) | [16.9 d](/filings/0001193125-26-083331.md) | [21.9](/filings/0000950170-25-063508.md) | [19.5 d](/filings/0000950170-25-105641.md) | [19.7 d](/filings/0001193125-25-266346.md) | [15.9 d](/filings/0001193125-26-083331.md) | [16.7](/filings/0001193125-26-206922.md) | [20.4 d](/filings/0001193125-26-326418.md) | [21.5 d](/filings/0001193125-25-266346.md) | [11.1 d](/filings/0001193125-26-083331.md) | [15.8](/filings/0001193125-26-206922.md) | [23.3 d](/filings/0001193125-26-326418.md) |
| Dividends paid | $m | [0.0 d](/filings/0000950170-24-120803.md) | [0.0 d](/filings/0001193125-26-083331.md) | [0.0](/filings/0000950170-25-063508.md) | [0.0 d](/filings/0000950170-25-105641.md) | [0.0 d](/filings/0001193125-25-266346.md) | [0.0 d](/filings/0001193125-26-083331.md) | [0.0](/filings/0000950170-25-063508.md) | [0.0 d](/filings/0000950170-25-105641.md) | [0.0 d](/filings/0001193125-25-266346.md) | [0.0 d](/filings/0001193125-26-083331.md) | not reported | not reported |
| Share repurchases | $m | [4.3 d](/filings/0000950170-24-120803.md) | [6.7 d](/filings/0001193125-26-083331.md) | [0.0](/filings/0000950170-25-063508.md) | [8.8 d](/filings/0000950170-25-105641.md) | [8.2 d](/filings/0001193125-25-266346.md) | [8.0 d](/filings/0001193125-26-083331.md) | [14.1](/filings/0001193125-26-206922.md) | [15.1 d](/filings/0001193125-26-326418.md) | [33.2 d](/filings/0001193125-25-266346.md) | [5.4 d](/filings/0001193125-26-083331.md) | [5.3](/filings/0001193125-26-206922.md) | [2.4 d](/filings/0001193125-26-326418.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-27) | Q1 FY2023 (2023-04-04) | Q2 FY2023 (2023-07-04) | Q3 FY2023 (2023-10-03) | Q1 FY2024 (2024-04-02) | Q2 FY2024 (2024-07-02) | Q3 FY2024 (2024-10-01) | Q1 FY2025 (2025-04-01) | Q2 FY2025 (2025-07-01) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [23.4](/filings/0000950170-23-059349.md) | [23.9](/filings/0000950170-24-053699.md) | [24.0](/filings/0000950170-24-090952.md) | [23.5](/filings/0000950170-24-120803.md) | [24.0](/filings/0000950170-25-063508.md) | [23.9](/filings/0000950170-25-105641.md) | [23.1](/filings/0001193125-25-266346.md) | [23.3](/filings/0001193125-26-206922.md) | [23.0](/filings/0001193125-26-326418.md) | [22.5](/filings/0001193125-25-266346.md) | [21.9](/filings/0001193125-26-206922.md) | [21.9](/filings/0001193125-26-326418.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 21,273,765 at 2026-07-28, from the cover of the [10-Q filed 2026-07-31](/filings/0001193125-26-326418.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.